49 Matching Annotations
  1. Last 7 days
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC13288474/
  3. May 2026
  4. febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com
    FEBS Press
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.70375
  5. www.sciencedirect.com www.sciencedirect.com
    mRNA delivery of mosaic-8 pan-sarbecovirus RBD vaccines elicits distinct antibody epitope signatures
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124726004134
  6. Apr 2026
  7. www.sciencedirect.com www.sciencedirect.com
    Broad-spectrum coronavirus inhibition by RSV fusion inhibitors targeting six-helix bundle formation
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0024320526001669
  8. Oct 2025
  9. www.biorxiv.org www.biorxiv.org
    mRNA delivery of genetically encoded mosaic-8 pan-sarbecovirus RBD vaccines
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.10.21.683747v1
  10. 54.241.53.176 54.241.53.176
    1-s2.0-S2589004225019108-main-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    54.241.53.176/a2cead7372cd5656ca58f963b054c227add92e0d/1-s2.0-S2589004225019108-main-html.html
  11. Jul 2025
  12. www.biorxiv.org www.biorxiv.org
    Single administration of mosaic-8b RBD-nanoparticle vaccine prepared with atomic layer deposition technology elicits broadly neutralizing anti-sarbecovirus responses
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2025.06.16.660007v1
  13. May 2025
  14. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Neutralization and spike stability of JN.1-derived LB.1, KP.2.3, KP.3, and KP.3.1.1 subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12077133/
  15. Apr 2025
  16. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11998534/
  17. journals.asm.org journals.asm.org
    Role of glycosylation mutations at the N-terminal domain of SARS-CoV-2 XEC variant in immune evasion, cell-cell fusion, and spike stability
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    journals.asm.org/doi/10.1128/jvi.00242-25
  18. Jan 2025
  19. www.sciencedirect.com www.sciencedirect.com
    Designed mosaic nanoparticles enhance cross-reactive immune responses in mice
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424014284
  20. Dec 2024
  21. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    Immune Evasion, Cell-Cell Fusion, and Spike Stability of the SARS-CoV-2 XEC Variant: Role of Glycosylation Mutations at the N-terminal Domain
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC11601353/
  22. Sep 2024
  23. www.sciencedirect.com www.sciencedirect.com
    Discovery and characterization of a pan-betacoronavirus S2-binding antibody
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0969212624003691
  24. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralization and Stability of JN.1-derived LB.1, KP.2.3, KP.3 and KP.3.1.1 Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11398412/
  25. Aug 2024
  26. www.sciencedirect.com www.sciencedirect.com
    Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424008468
  27. Jul 2024
  28. www.cell.com www.cell.com
    Neutralization escape, infectivity, and membrane fusion of JN.1-derived SARS-CoV-2 SLip, FLiRT, and KP.2 variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    cell.com/cell-reports/abstract/S2211-1247(24)00849-0
  29. May 2024
  30. www.biorxiv.org www.biorxiv.org
    Characteristics of JN.1-derived SARS-CoV-2 subvariants SLip, FLiRT, and KP.2 in neutralization escape, infectivity and membrane fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.05.20.595020v1
  31. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11077997/
  32. Apr 2024
  33. www.biorxiv.org www.biorxiv.org
    Distinct Patterns of SARS-CoV-2 BA.2.87.1 and JN.1 Variants in Immune Evasion, Antigenicity and Cell-Cell Fusion
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.03.11.583978v1
  34. Mar 2024
  35. onlinelibrary.wiley.com onlinelibrary.wiley.com
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    onlinelibrary.wiley.com/doi/10.1002/jmv.29520
  36. Feb 2024
  37. www.biorxiv.org www.biorxiv.org
    Mosaic sarbecovirus vaccination elicits cross-reactive responses in pre-immunized animals
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    biorxiv.org/content/10.1101/2024.02.08.576722v1
  38. Jan 2024
  39. www.sciencedirect.com www.sciencedirect.com
    Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867423014009
  40. Dec 2023
  41. www.sciencedirect.com www.sciencedirect.com
    Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1074761323004855
  42. Nov 2023
  43. link.springer.com link.springer.com
    SARS-CoV-2 ORF6 protein targets TRIM25 for proteasomal degradation to diminish K63-linked RIG-I ubiquitination and type-I interferon induction
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    link.springer.com/article/10.1007/s00018-023-05011-3
  44. Oct 2023
  45. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10606793/
  46. www.sciencedirect.com www.sciencedirect.com
    Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223020862
  47. www.sciencedirect.com www.sciencedirect.com
    Continued evasion of neutralizing antibody response by Omicron XBB.1.16
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723012056
  48. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10515800/
  49. Jun 2023
  50. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Significant Broad-Spectrum Antiviral Activity of Bi121 against Different Variants of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10305169/
  51. May 2023
  52. www.sciencedirect.com www.sciencedirect.com
    Neutralization Escape of Omicron XBB, BR.2, and BA.2.3.20 Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379123001635
  53. Apr 2023
  54. www.sciencedirect.com www.sciencedirect.com
    Enhanced Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124723004540
  55. Mar 2023
  56. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9972997/
  57. Feb 2023
  58. www.sciencedirect.com www.sciencedirect.com
    Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2589004223002031
  59. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Extraordinary Evasion of Neutralizing Antibody Response by Omicron XBB.1.5, CH.1.1 and CA.3.1 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9882202/
  60. Jan 2023
  61. journals.asm.org journals.asm.org
    Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    journals.asm.org/doi/10.1128/mbio.03176-22
  62. Dec 2022
  63. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Enhanced Neutralization Resistance of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9678813/
  64. Nov 2022
  65. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralizing monoclonal antibodies elicited by mosaic RBD nanoparticles bind conserved sarbecovirus epitopes
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9606073/
  66. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Distinct Neutralizing Antibody Escape of SARS-CoV-2 Omicron Subvariants BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9603827/
  67. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Determinants and Mechanisms of the Low Fusogenicity and Endosomal Entry of Omicron Subvariants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9603825/
  68. Oct 2022
  69. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Evasion of Neutralizing Antibody Responses by the SARS-CoV-2 BA.2.75 Variant
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9515334/
  70. 52.53.155.43 52.53.155.43
    A Microarray Patch SARS-CoV-2 Vaccine Induces Sustained Antibody Responses and Polyfunctional Cellular Immunity
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/930bc08144a97604b3aba650218d62e0f5ec0931/1-s2.0-S2589004222013177-main-html.html
  71. Sep 2022
  72. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Recent infection with HCoV-OC43 may be associated with protection against SARS-CoV-2 infection
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9458542/
  73. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Evasion of Neutralizing Antibody Response by the SARS-CoV-2 BA.2.75 Variant
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9413709/
  74. Aug 2022
  75. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9353602/
  76. 52.53.155.43 52.53.155.43
    https://medrxiv.org/cgi/content/10.1101/2022.01.03.21268582
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/29c3e315cf2d23005021f240f790281059e1fe7d/2022.01.03.21268582.full-html.html
  77. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9327628/
  78. May 2022
  79. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Neutralization of SARS-CoV-2 Omicron Sub-lineages BA.1, BA.1.1, and BA.2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9035359/
  80. Apr 2022
  81. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC9018067/
  82. Aug 2021
  83. www.sciencedirect.com www.sciencedirect.com
    Identification of COVID-19 prognostic markers and therapeutic targets through meta-analysis and validation of Omics data from nasopharyngeal samples
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2352396421003182